newsfilter
← Latest News
Business Wire·

Adicet Bio to Participate in Upcoming Investor Conferences

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and